Abstract

Neuroendocrine tumors (NETs) are a diverse group of cancers, increasing in frequency, which can arise virtually anywhere in the body from cells of both the endocrine and nervous systems. Even given their diversity, NETs generally share common histologic features, and most (up to 85% of non-incidental NETs) are "functional" in the sense that they produce hormones. Most clinically apparent NETs arise in the intestine or lungs, and are often grouped into foregut (including pancreas and lung), midgut, and hindgut tumors. Of the gastroenteropancreatic tumors, carcinoids (oddly named because they grew slowly and were thought to only be "cancer-like") comprise ~2/3, while pancreatic endocrine tumors comprise the remaining ~1/3.

Original languageEnglish (US)
Pages (from-to)3-5
Number of pages3
JournalTranslational Cancer Research
Volume2
Issue number1
DOIs
StatePublished - Feb 1 2013

Fingerprint

Neuroendocrine Tumors
Neoplasms
Lung
Endocrine System
Carcinoid Tumor
Nervous System
Intestines
Pancreas
Hormones

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

@article{172078c87d234a78aa1713e370d9c2b7,
title = "From devils to jobs: Tracking neuroendocrine tumors",
abstract = "Neuroendocrine tumors (NETs) are a diverse group of cancers, increasing in frequency, which can arise virtually anywhere in the body from cells of both the endocrine and nervous systems. Even given their diversity, NETs generally share common histologic features, and most (up to 85{\%} of non-incidental NETs) are {"}functional{"} in the sense that they produce hormones. Most clinically apparent NETs arise in the intestine or lungs, and are often grouped into foregut (including pancreas and lung), midgut, and hindgut tumors. Of the gastroenteropancreatic tumors, carcinoids (oddly named because they grew slowly and were thought to only be {"}cancer-like{"}) comprise ~2/3, while pancreatic endocrine tumors comprise the remaining ~1/3.",
author = "Gary Clawson",
year = "2013",
month = "2",
day = "1",
doi = "10.3978/j.issn.2218-676X.2013.02.05",
language = "English (US)",
volume = "2",
pages = "3--5",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",
number = "1",

}

From devils to jobs : Tracking neuroendocrine tumors. / Clawson, Gary.

In: Translational Cancer Research, Vol. 2, No. 1, 01.02.2013, p. 3-5.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - From devils to jobs

T2 - Tracking neuroendocrine tumors

AU - Clawson, Gary

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Neuroendocrine tumors (NETs) are a diverse group of cancers, increasing in frequency, which can arise virtually anywhere in the body from cells of both the endocrine and nervous systems. Even given their diversity, NETs generally share common histologic features, and most (up to 85% of non-incidental NETs) are "functional" in the sense that they produce hormones. Most clinically apparent NETs arise in the intestine or lungs, and are often grouped into foregut (including pancreas and lung), midgut, and hindgut tumors. Of the gastroenteropancreatic tumors, carcinoids (oddly named because they grew slowly and were thought to only be "cancer-like") comprise ~2/3, while pancreatic endocrine tumors comprise the remaining ~1/3.

AB - Neuroendocrine tumors (NETs) are a diverse group of cancers, increasing in frequency, which can arise virtually anywhere in the body from cells of both the endocrine and nervous systems. Even given their diversity, NETs generally share common histologic features, and most (up to 85% of non-incidental NETs) are "functional" in the sense that they produce hormones. Most clinically apparent NETs arise in the intestine or lungs, and are often grouped into foregut (including pancreas and lung), midgut, and hindgut tumors. Of the gastroenteropancreatic tumors, carcinoids (oddly named because they grew slowly and were thought to only be "cancer-like") comprise ~2/3, while pancreatic endocrine tumors comprise the remaining ~1/3.

UR - http://www.scopus.com/inward/record.url?scp=84962775693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962775693&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2218-676X.2013.02.05

DO - 10.3978/j.issn.2218-676X.2013.02.05

M3 - Editorial

AN - SCOPUS:84962775693

VL - 2

SP - 3

EP - 5

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

IS - 1

ER -